Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05895032

Trial of an Exercise Intervention for Children With Haemophilia

"Being able to participate in games and activities with their friends" is one of the things that matters most to boys with haemophilia. At present, there is a lack of robust evidence to determine whether muscle strengthening exercise can improve or negatively affect outcomes for young children with haemophilia. With the help of boys with haemophilia, their parents and physiotherapists the investigators have developed an exercise programme designed to increase muscle strength. Using this intervention the investigators will undertake a single-blinded, two-arm pragmatic randomised controlled trial (RCT) of a 12-week intervention verses usual care of boys with haemophilia aged 6-12 years of age.

Recruiting

Interested in participating?

Request Info

Key information

Age range

6 year–12 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Haemophilia Centre

Canterbury, Kent, CT1 3NG, United Kingdom

Location status: Recruiting

Location contact

David Stephensen, PhD

CONTACT

About this study

Children are born with haemophilia. Females carry the disorder and usually males are affected. It is a disorder affecting 1:10000 people where the blood does not clot normally, leading to bleeding into muscles and joints. As a result, muscles become weak. Joints become painful and difficult to move. "Being able to participate in games and activities with their friends" is one of the things that matters most to boys with haemophilia. "What is the role of exercise for both prevention and treatment of joint damage in haemophilia?" is one of the top unanswered questions that concern patients, carers and healthcare professionals most. At present, there is a lack of robust evidence to determine whether muscle strengthening exercise can improve or negatively affect outcomes for young children with haemophilia. With the help of boys with haemophilia, their parents and physiotherapists the investigators have developed an exercise programme designed to increase muscle strength. The investigators think the exercise programme might have an effect on pain and movement in participants joints, help them participate in games and activities with their friends and improve their health in the long term. The investigators recently showed the exercise programme had no harmful effects, was acceptable to children with haemophilia and that the participants were willing to participate in a study to answer the question, "does muscle strengthening help improve the long term health of children with haemophilia?" To answer this question, the investigators will allocate 66 boys with haemophilia to a group that is asked to complete the 12-week exercise routine to strengthen their leg muscles and another 66 boys to a group that does not do the exercises. The boys will be allocated at random, so that each boy has an equal chance of being in either group. Random allocation helps ensure that two similar groups of boys will be compared. The investigators will monitor the boys throughout the study by measuring their muscle strength, how far they can walk in six-minutes and time taken to ascend and descend 12 steps. The investigators will also record how physically active the boys are using a wrist band as well as how satisfied they are with their health. The study will be managed by a group of health care professionals and researchers with experience and expertise in carrying out this type of research. In addition, the investigators will include parents of boys with haemophilia in the research team to provide invaluable lived experience of living with the condition. So that people hear about what the investigators learn in the study, the investigators will report the findings to other researchers using journals, relevant health care professionals through face to face meetings, and children with haemophilia and their families through newsletters and presentations at Haemophilia Society meetings.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Children aged 6-12 years, with severe or moderate haemophilia A or B

Exclusion criteria

  • von Willebrand disease
  • past history of fracture or trauma to the lower limb
  • orthopaedic surgery
  • acquired brain injury or any other disturbance of the central nervous system; joint or muscle bleed in the lower limb in the past 6 weeks
  • presence of lower limb pain or unable to fully comply with verbal instructions.

Treatment and study plan

Exercise

Other

12-week exercise intervention

Usual Care

Other

usual care

Primary outcomes

  1. Muscle strength of the dominant knee extensors at 24 weeks

    Time frame: 24-weeks

    Maximum isometric torque (Newton.metres/kilogram of body weight)

Secondary outcomes

  1. Muscle strength of the ankle plantarflexors and non-dominant knee extensors at 24 weeks

    Time frame: 24 weeks

    maximum isometric torque (Newton.metres/kilogram of body weight)

  2. Bleeding episodes and coagulation factor usage

    Time frame: 24 weeks

    Number of bleeding episodes (number) and amount of coagulation factor used for treatment (number)

  3. Six-minute timed walk (6MTW)

    Time frame: 24 weeks

    Distance walked in 6 minutes (metres)

  4. Timed up and down stairs (TUDS)

    Time frame: 24 weeks

    Time taken to ascend and descend a flight of 12 steps (seconds)

  5. Participation in physical activity

    Time frame: 24 weeks

    Time spent in moderate-vigorous physical activity physical activity (MVPA)

  6. Child Health Utility 9D (CHU9D)

    Time frame: 24 weeks

    a paediatric preference based measure of health related quality of life (utility values on the 0.0 to 1.0 quality adjusted life year scale) Higher score represent higher adjusted life years.

Study contacts

Contact information is provided by the study sponsor or research team.

David Stephensen, PhD

CONTACT

[email protected]

01227783166

Sponsors and collaborators

Lead sponsor

East Kent Hospitals University NHS Foundation Trust

Other Gov

Collaborators

  • Great Ormond Street Hospital for Children NHS Foundation Trust
  • University of Kent

Registry information

Official study title

Development Of a haemophiLia PHysiotherapy INtervention for Optimum Musculoskeletal Health in Children (DOLPHIN-II) - a Randomised Controlled Trial

Acronym: DOLPHIN-II

Important dates

Study start
2021
Primary completion
2025
Study completion
2025
First posted
Jun 8, 2023
Registry last updated
Aug 30, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.